SECTION 1. Chapter 10 of the General Laws is hereby amended by inserting after section 35MMM, added by section 9 of chapter 41 of the acts of 2019, the following section:-

Section 35NNN. (a) There shall be an Epinephrine Auto-Injectors Bulk Purchase Fund. The fund shall be administered and expended by the commissioner of public health or a designee for the operation of the epinephrine auto-injectors bulk purchase program. Residents of  the Commonwealth may purchase epinephrine auto-injectors directly through the program. The state office of pharmacy services shall assist with the purchasing and distribution of epinephrine auto-injectors Injectors on behalf of the program.

(b) The fund shall consist of: (i) payments made by program participants for the purchase of epinephrine auto-injectors; (ii) revenue from appropriations or other monies authorized by the general court and specifically designated to be credited to the fund; and (iii) funds from public or private sources including, but not limited to, gifts, grants, donations, rebates and settlements received by the commonwealth that are specifically designated to be credited to the fund. Amounts credited to the fund shall not be subject to further appropriation and monies remaining in the fund at the end of a fiscal year shall not revert to the General Fund.

SECTION 2. (a) There shall be established, pursuant to section 2A of chapter 4 of the General Laws, a special commission to study and make recommendations concerning the allocation of funds in the Epinephrine Auto-Injectors Bulk Purchase Fund and the implementation of the epinephrine auto-injectors bulk purchase program. The commission shall consist of 9 members; 1 member of the House of Representatives, to be appointed by the Speaker of the House of Representatives, who shall serve as co-chair; 1 member of the House of Representatives, to be appointed by the Minority Leader of the House of Representatives; 1 member of the Senate, to be appointed by the President of the Senate, who shall serve as co-chair; 1 member of the Senate, to be appointed by the Minority Leader of the Senate; the Commissioner of Public Health; 1 person to be appointed by the President of the Senate, who shall be a medical doctor who specializes in Immunology and is licensed to practice in the Commonwealth;  1 person to be appointed by the Speaker of the House of Representatives, who shall be a certified school nurse in the Commonwealth and 2 members to be appointed by the Governor, 1 of whom shall be a pharmacist licensed to practice in the Commonwealth  and 1 of whom shall be a representative of a pharmaceutical company. 

(b) The commission shall report its findings and recommendations to the Governor and the clerks of the House of Representatives and the Senate, including any recommendations for legislation or regulations, within 4 months of the effective date of this act.